Article
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19.
Scientific reports - 28 Dec 2022
Blair Paul W, Brandsma Joost, Chenoweth Josh, Richard Stephanie A, Epsi Nusrat J, Mehta Rittal, Striegel Deborah, Clemens Emily G, Alharthi Sultanah, Lindholm David A, Maves Ryan C, Larson Derek T, Mende Katrin, Colombo Rhonda E, Ganesan Anuradha, Lalani Tahaniyat, Colombo Christopher J, Malloy Allison A, Snow Andrew L, Schully Kevin L, Lanteri Charlotte, Simons Mark P, Dumler John S, Tribble David, Burgess Timothy, Pollett Simon, Agan Brian K, Clark Danielle V
Abstract excerpt
The associations between clinical phenotypes of coronavirus disease 2019 (COVID-19) and the host inflammatory response during the transition from peak illness to convalescence are not yet well understood. Blood plasma samples were collected from 129 adult SARS-CoV-2 positive inpatient and outpatient participants between April 2020 and January 2021, in a multi-center prospective cohort study at 8 military...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.